Severe valvular regurgitation: An unexpected complication during transapical aortic valve implantation treated successfully with the “Valve-in-valve” procedure

Severe symptomatic aortic stenosis (AS) in a multimorbid 77 year old female was treated with transapical aortic valve implantation with a 23 mm Edwards Sapien valve. Severe valvular regurgitation following implantation, probably due to structural valve failure, was treated successfully with a second valve-in- valve implantation. During a follow-up time of 2,5 years no further problems occurred.

PDF

___

1. Webb JG, Pasupati S, Humphries K, Thompson C, Altwegg L, Moss R, et al. Percutaneous transarterial aortic valve replacement in selected high risk patients with aortic stenosis. Circulation 2007;116:755-63. [CrossRef]
2. Walther T, Simon P, Dewey T, Wimmer-Greinecker G, Falk V, Kasimir MT, et al. Transapical minimally invasive aortic valve implantation: multicenter experience. Circulation 2007;116:240-5. [CrossRef]
3. Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, Bauer F, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002;106:3006-8. [CrossRef]
4. Ducrocq G, Francis F, Serfaty JM, Himbert D, Maury JM, Pasi N, et al. Vascular complications of transfemoral aortic valve implantation with the Edwards SAPIEN prosthesis: incidence and impact on outcome. EuroIntervention 2010;5:666-72. [CrossRef]
5. Van Mieghem NM, Nuis RJ, Piazza N, Apostolos T, Ligthart J, Schultz C, et al. Vascular complications with transcatheter aortic valve implantation using the 18 Fr Medtronic Core Valve System: the Rotterdam experience. EuroIntervention 2010;5:673-9. [CrossRef]
6. Sinhal A, Altwegg L, Pasupati S, Humphries KH, Allard M, Martin P, et al. Atrioventricular block after transcatheter balloon expand- able aortic valve implantation. JACC Cardiovasc Interv 2008;1:305-9. [CrossRef]
7. Masson JB, Kovac J, Schuler G, Ye J, Cheung A, Kapadia S, et al. Transcatheter aortic valve implantation: review of the nature, management, and avoidance of procedural complications. JACC Cardiovasc Interv 2009;2:811-20. [CrossRef]
8. Grube E, Schuler G, Buellesfeld L, Gerckens U, Linke A, Wenaweser P, et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30- day clinical outcome. J Am Coll Cardiol 2007;50:69-76. [CrossRef]
9. Rodes-Cabau J, Dumont E, Doyle D. Valve in valve for the treatment of paravalvular leaks following transcatheter aortic valve implantation. Catheter Cardiovasc Interv 2009;74:1116-9. [CrossRef]
10. Sherif MA, Abdel-Wahab M, Stöcker B, Geist V, Richardt D, Tölg R, et al. Anatomic and procedural predictors of paravalvular aortic regurgitation after implantation of the Medtronic CoreValve bioprosthesis. J Am Coll Cardiol 2010;56:1623-9. [CrossRef]
11. Al-Attar N, Ghodbane W, Himbert D, Rau C, Raffoul R, Messikazeitoun D, et al. Unexpected complications of transapical aortic valve implantation. Ann Thorac Surg 2009;88:90-4. [CrossRef]
12. Schaff HV. Transcatheter aortic-valve implantation--at what price? N Engl J Med 2011;364:2256-8.